Jack Mozloom, vice president of Public Affairs at the National Community Pharmacists Association (NCPA), speaks with Matt Seiler, general counsel at NCPA, about the current PBM litigation at the 2023 NCPA Convention.
Key Takeaways:
Osterhaus Pharmacy has filed a class action lawsuit against CVS Health, Caremark, and Aetna, alleging violations of federal antitrust laws and state contract laws related to Medicare Part D prescription fees.
The lawsuit focuses on the unfair imposition of pharmacy direct and indirect remuneration (DIR) fees, which have been a source of concern for independent pharmacies and their organizations like the NCPA.
The legal action aims to recover damages and address various claims, including the unfair imposition of fees, breach of good faith and fair dealing, and unjust enrichment.
Print Page
Email to a Friend